Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Cridland NA et al. | 1996 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz, power transmission line | 20 µT–20 mT |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
Huang L et al. | 2006 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) and SK-Hep-1 (hepatocellular carcinoma cells) | magnetic field, 50/60 Hz | 20 mT |
Yoshizawa H et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia), MCF-7 (breast carcinoma), A-375 (malignant melanoma), H4 (glioma) | magnetic field, low frequency, 50/60 Hz | 2–500 µT |
Wolf FI et al. | 2005 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells); WI-38 (embryonic human lung fibroblasts); Rat-1 (rat fibroblasts) | magnetic field, 50/60 Hz | 500 µT–1 mT |
Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
Bajtoš M et al. | 2024 | intact cell/cell culture, HT-1080 (fibrosarcoma cells) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
Manni V et al. | 2002 | intact cell/cell culture, HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz | 2 mT |
Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.